General Information of the Compound
Compound ID |
CP0340527
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-(1H-benzimidazol-2-yl)-3-nitrobenzamide
Show/Hide
|
||||||||||||||||||
Synonyms |
3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide
301675-24-1
AC1MTB3N
AKOS001141441
AKOS001825502
BDBM50184701
CHEMBL210658
CS-13909
CS-M1436
Cambridge id 7283005
KB-78995
MCULE-1403873826
MLS000418401
MolPort-001-543-036
MolPort-007-653-805
N-(1H-benzimidazol-2-yl)-3-nitrobenzamide
N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide
N-benzimidazol-2-yl(3-nitrophenyl)carboxamide
Oprea1_144350
Oprea1_384876
QPKROMNIEAEFQA-UHFFFAOYSA-N
SCHEMBL3597174
SMR000264931
ST50927847
STK433528
ZINC5033955
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C14H10N4O3
|
||||||||||||||||||
Molecular Weight |
282.259
|
||||||||||||||||||
Canonical SMILES |
[O-][N+](=O)c1cccc(c1)C(=O)Nc1nc2ccccc2[nH]1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C14H10N4O3/c19-13(9-4-3-5-10(8-9)18(20)21)17-14-15-11-6-1-2-7-12(11)16-14/h1-8H,(H2,15,16,17,19)
Show/Hide
|
||||||||||||||||||
InChIKey |
QPKROMNIEAEFQA-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound